Search
for
Sort by
Research 211–240 of 1000+
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- ‘Post-finasteride syndrome’: what to tell our female patients?
- Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States
- The exploration of mitochondrial‐related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer
- Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Plant responses to shade
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- 182 Retinol remarkably effective in reducing neck wrinkles
- Abstract 2469: Increased cathepsin B expression in cultured tuberous sclerosis skin tumor cells and patient tumor tissues
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis
- Management of Facial Hair in Women
- Abstracts of the Final Year Projects of Pharm D Clinical Pharmacy Students Faculty of Pharmacy Beni-suef University Year 2024/2025
- VDAC2 Mediates the Apoptosis of Cashmere Goat Hair Follicle Stem Cells Through the P53 Signaling Pathway
- COVID-19 Infection and Vaccination Effects on Breast Implant Illness: A Case Report
- Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen
- ISID1394 - Long non-coding RNA AL136131.3 inhibits hair growth through mediating glycolysis in androgenetic alopecia
- (423) A Case Series of Successful Off-label Use of Flibanserin
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Evaluation of Short-Term Efficacy and Long-Term Oncologi-Cal Outcomes of Different Paclitaxels Plus Platinum Regi-Mens in the Treatment of Serous Ovarian Cancer—A Real World Study
- 15460 Perifollicular pink halo: A potential dermoscopic marker of inflammation in central centrifugal cicatricial alopecia
- Developing Optical Biometrics Using Optical Coherence Tomography for Medical Screening and Diagnosis
- Research Snippets
- Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats
- A PAX1 enhancer locus is associated with susceptibility to idiopathic scoliosis in females
- Psychological and psychiatric characterization of various groups of drugs users
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For